Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma

Xiang Zhou; Rongjian Xu; Tong Lu; Ran Xu; Chenghao Wang; Bo Peng; Xiaoyan Chang; Zhiping Shen; Kaiyu Wang; Jiaxin Shi; Jiaying Zhao; Lin-You Zhang

doi:doi:10.18632/aging.204957

← Back

Research Paper Volume 15, Issue 16 pp 8090—8112

Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma

Figure 6. MS4A6A expression was positively correlated with ICP-related genes. (A) Correlation of MS4A6A expression with ICP-related genes. (B) Comparison of MS4A6A expression with common immune checkpoint expression in TCGA-LUAD cohort. (C) Correlation of MS4A6A expression profile with ICP-related genes in the pan-cancer cohort. ^**P < 0.01, ^***P < 0.001.